Israeli medical technology company Given Imaging has got green signal from U.S. Food and Drug Administration for a pill to provide visualization of the colon that has a global market of 3 million procedures a year.
The FDA gave its clearance to the camera-in-a-pill maker for the pill called PillCam Colon,that can be used for detection of colon polyps in patients after an incomplete optical colonoscopy.
According to Given Imaging reports, as many as 750,000 Americans experience an incomplete colonoscopy each year.
The incomplete procedure often incurs additional costs to the patients, along with the inconvenience and risk associated with other procedures to complete the colorectal examination.
Given Imaging is Israel-based developer of technology for visualizing, diagnosing and monitoring the digestive system, including its PillCam. The pill is a swallowed capsule endoscope.
Last year, medical device maker Covidien PLC announced acquiring of Given Imaging for $860 million. The transaction is expected to be completed by March 31 this year.
